Nanotechnology for Neuroscience: Promising Approaches for Diagnostics, Therapeutics and Brain Activity Mapping

Abstract

Unlocking the secrets of the brain is a task fraught with complexity and challenge – not least due to the intricacy of the circuits involved. With advancements in the scale and precision of scientific technologies, we are increasingly equipped to explore how these components interact to produce a vast range of outputs that constitute function and disease. Here, an insight is offered into key areas in which the marriage of neuroscience and nanotechnology has revolutionized the industry. The evolution of ever more sophisticated nanomaterials culminates in network-operant functionalized agents. In turn, these materials contribute to novel diagnostic and therapeutic strategies, including drug delivery, neuroprotection, neural regeneration, neuroimaging and neurosurgery. Further, the entrance of nanotechnology into future research arenas including optogenetics, molecular/ion sensing and monitoring, and piezoelectric effects is discussed. Finally, considerations in nanoneurotoxicity, the main barrier to clinical translation, are reviewed, and direction for future perspectives is provided.

Blood-Brain Barrier Permeable Chitosan Oligosaccharides Interfere with β-Amyloid Aggregation and Alleviate β-Amyloid Protein Mediated Neurotoxicity and Neuroinflammation in a Dose- and Degree of Polymerization-Dependent Manner

“…However, these studies were mainly verified by in vitro cellular models, and whether COS can reach the brain to exert their neuroprotective effects directly remains elusive. BBB is an impediment for the delivery of therapeutic agents to the brain [ 32 ]. In this study, to determine the permeation ability of COS across the BBB in vitro, a single layer of brain microvascular bEnd.3 cells as a BBB model in vitro was used ( Figure 2 A).…”

Recent Progress of Nanomedicine in the Treatment of Central Nervous System Diseases

“…With that, the tracking and assessing of transplanted neural stem cell in vivo and in situ become achievable. This makes the transplant of neural stem cell visible, which means it is extremely reliable as a therapeutic method …”

A Conditionally Releasable “Do not Eat Me” CD47 Signal Facilitates Microglia‐Targeted Drug Delivery for the Treatment of Alzheimer's Disease

“…[ 1 ] Many therapeutic approaches based on the pathogenesis theories for AD treatment have failed in clinical trials, [ 2 ] partly due to the poor brain bioavailability induced by blood‐brain barrier (BBB). [ 3 ] These failures call for new and efficient brain delivery strategies to cure or prevent AD.…”